What is the differential diagnosis (DDX) of non-specific intestinal necrosis (NSIN) on computed tomography (CT) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis of Non-Specific Intestinal Necrosis (NSIN) on CT Scan

When CT demonstrates intestinal necrosis without a clear etiology, the differential diagnosis must prioritize mesenteric ischemia (both occlusive and non-occlusive), followed by infectious/inflammatory enterocolitis, and less commonly radiation enteritis, drug-induced injury, or vasculitis. 1, 2, 3

Primary Differential Considerations

1. Mesenteric Ischemia (Most Critical)

Arterial Occlusive Disease:

  • Superior mesenteric artery (SMA) embolism or thrombosis is the most common cause of intestinal necrosis requiring immediate intervention 1, 2
  • CT findings include vessel occlusion, reduced bowel wall enhancement, pneumatosis intestinalis, and portal venous gas 1, 2
  • CTA is the diagnostic modality of choice to identify arterial compromise 1, 2

Non-Occlusive Mesenteric Ischemia (NOMI):

  • Occurs in critically ill patients with low-flow states, particularly those on vasopressors 2, 4
  • CT may show bowel wall thinning, decreased enhancement, and mesenteric vessel narrowing without occlusion 2, 4
  • Mortality exceeds 50-70% even with treatment 2, 5
  • Plasma I-FABP >3114 pg/mL has 90% positive predictive value for intestinal necrosis 4

Mesenteric Venous Thrombosis:

  • Less common cause but presents with bowel wall thickening, mesenteric stranding, and venous filling defects 2
  • May have more indolent presentation than arterial occlusion 2

2. Infectious Enterocolitis

Clostridium difficile Colitis:

  • Can cause severe pancolitis with necrosis, particularly in immunocompromised patients 1, 3
  • "Giraffe coat" sign on CT (accordion-like pattern of thickened haustral folds) is relatively specific 3
  • Preferentially affects the colon with marked wall thickening and pericolonic stranding 3

Cytomegalovirus (CMV) Enterocolitis:

  • Occurs in immunocompromised patients (HIV, transplant recipients, IBD patients on immunosuppression) 1, 6
  • CT shows variable findings from patchy erythema to deep ulcers and pseudotumors 1
  • Can mimic Crohn's disease with discontinuous involvement 1

Other Bacterial Infections:

  • Salmonella, Shigella, Campylobacter can cause severe colitis mimicking ulcerative colitis 1, 3
  • Yersinia enterocolitis can resemble Crohn's disease with terminal ileal involvement 1
  • Intestinal tuberculosis affects terminal ileum/ileocecal region in 50% of cases, particularly in immunocompromised patients 1

3. Inflammatory Bowel Disease Complications

Crohn's Disease with Stricture and Ischemia:

  • Strictures defined as luminal narrowing with upstream dilation >3-4 cm 1
  • Can progress to penetrating complications (fistula, abscess) or ischemic necrosis 1
  • Look for asymmetric wall thickening, mesenteric fat stranding, and engorged vasa recta 1

Severe Ulcerative Colitis:

  • Continuous colonic involvement with rectal sparing rare 1
  • Toxic megacolon can lead to perforation and necrosis 1

4. Drug-Induced and Toxic Causes

NSAID Enteropathy:

  • Can cause ulceration and strictures throughout small bowel 1, 3
  • Often presents with non-specific inflammation and potential perforation 1

Radiation Enteritis:

  • History of pelvic or abdominal radiation therapy is key 3, 6
  • Affects bowel segments within radiation field with wall thickening and strictures 3, 6

Graft-Versus-Host Disease:

  • Occurs in bone marrow transplant recipients 3, 6
  • Diffuse small bowel involvement with wall thickening and mucosal sloughing 3, 6

5. Vasculitis and Infiltrative Disorders

Behçet Disease:

  • Can cause intestinal ulceration and necrosis 6
  • Look for multisystem involvement and oral/genital ulcers clinically 6

Amyloidosis:

  • Infiltrative process causing wall thickening and potential ischemia 6
  • Rare cause but consider in patients with systemic amyloidosis 6

Critical Diagnostic Approach

Immediate Assessment:

  • Obtain CTA abdomen/pelvis if not already performed to evaluate vascular patency and identify active bleeding 1, 2
  • Look for pneumatosis intestinalis and portal venous gas (indicate transmural necrosis) 1, 2
  • Assess bowel wall enhancement pattern: absent enhancement = necrosis 1, 2

Clinical Context Integration:

  • Age >60 years, atrial fibrillation, recent MI = embolic arterial occlusion 1, 2
  • ICU patient on vasopressors = NOMI 2, 4
  • Immunocompromised state = infectious causes (CMV, TB, fungal) 1
  • Recent antibiotics = C. difficile colitis 1, 3
  • IBD history = disease complication or superimposed infection 1

Distribution Pattern Analysis:

  • SMA territory (jejunum to mid-transverse colon) = arterial occlusion 1, 2
  • Watershed areas (splenic flexure, rectosigmoid) = low-flow ischemia 1
  • Pancolitis = C. difficile, severe UC, or ischemic colitis 1, 3
  • Terminal ileum/ileocecal = Crohn's, TB, Yersinia 1

Common Pitfalls to Avoid

  • Do not delay surgical consultation while pursuing additional imaging if peritoneal signs are present 1, 2
  • Do not assume normal lactate excludes mesenteric ischemia - lactate elevation is a late finding 1, 5
  • Do not rely on standard CT with contrast alone - CTA with arterial phase is essential for vascular assessment 1, 2
  • Do not overlook NOMI in critically ill patients - conventional angiography may be needed for diagnosis and treatment 2
  • Serial examinations are mandatory when observation is chosen, as peritoneal signs may take hours to develop 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management and Treatment of Mesenteric Ischemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

CT of nonneoplastic diseases of the small bowel: spectrum of disease.

Journal of computer assisted tomography, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.